The drug may contain as little as 87 percent of the amount of levothyroxine the label says it has, Acella said. Levothyroxine is used to treat hypothyroidism, a condition in which thyroid glands don’t produce enough of certain crucial hormones. It can cause a number of health problems, such as obesity, joint pain, infertility and heart disease, according to Rochester, Minn.-based Mayo Clinic.
Patients taking the drug to treat hypothyroidism may experience symptoms including fatigue, slow heart rate, depression and swelling of the thyroid gland. There is a risk of serious injury in newborn infants or pregnant women with hypothyroidism who take the drug. Elderly patients and patients with underlying cardiac disease may experience cardiac pain, palpitations or cardiac arrhythmia, Acella said.
Acella has received four reports of adverse events that it says are possibly related to the recall.
Read the full news release here.
More articles on pharmacy:
Drug costs surge faster than any other medical good or service, data shows
Eli Lilly, Amgen partner to make Lilly’s COVID-19 antibody drug
Moderna will know if COVID-19 vaccine is effective in November, CEO says
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.